Sale!

KIF1A Gene Mental Retardation Autosomal Dominant Type 9 Genetic Test

4,400 د.إ

-21%

The KIF1A Gene Mental Retardation Autosomal Dominant Type 9 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the KIF1A gene, which are linked to a form of autosomal dominant mental retardation (Type 9). This condition is characterized by intellectual disabilities and, in some cases, neurological issues due to abnormalities in the KIF1A gene. The gene plays a crucial role in the transport of synaptic vesicles in neurons, and mutations can disrupt neural function and development.

The test is conducted through a detailed analysis of the patient’s DNA, extracted from a blood sample, to detect any alterations in the KIF1A gene that may be indicative of the condition. This genetic test is pivotal for families seeking answers to developmental delays and intellectual challenges in their loved ones, offering a pathway to targeted interventions and support.

At DNA Labs UAE, the cost of the KIF1A Gene Mental Retardation Autosomal Dominant Type 9 Genetic Test is set at 4400 AED. This investment covers the comprehensive genetic analysis and the professional expertise required to interpret the results accurately. Given the complexity of genetic conditions, obtaining a precise diagnosis can be invaluable for affected individuals and their families, guiding them towards appropriate care and management strategies.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

KIF1A Gene Mental Retardation Autosomal Dominant Type 9 Genetic Test

Overview

The KIF1A gene is associated with a condition called mental retardation, autosomal dominant type 9 (MRD9). This genetic test, known as Next-Generation Sequencing (NGS), is used to analyze the DNA sequence of the KIF1A gene to identify any mutations or variations that may be causing MRD9.

Symptoms and Diagnosis

MRD9 is a rare genetic disorder characterized by intellectual disability, developmental delays, and other neurological symptoms. Individuals with MRD9 may also experience problems with movement, speech, and coordination. The severity of symptoms can vary widely among affected individuals.

Test Details

The KIF1A Gene Mental Retardation Autosomal Dominant Type 9 Genetic Test is performed using NGS technology. This powerful genetic testing technique allows for the rapid and comprehensive analysis of a person’s DNA. It can detect a wide range of genetic mutations and variations, including small changes in the DNA sequence that may be responsible for causing MRD9.

Test Components and Price

  • Components: KIF1A Gene Mental retardation autosomal dominant type 9 Genetic Test
  • Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Test Type

Neurological Disorders

Referring Doctor and Test Department

Doctor: Neurologist

Test Department: Genetics

Pre Test Information

Clinical History of Patient who is going for KIF1A Gene Mental retardation, autosomal dominant type 9 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1A Gene Mental retardation, autosomal dominant type 9.

Importance of Genetic Testing

By identifying specific mutations in the KIF1A gene, NGS testing can provide a definitive diagnosis of MRD9. This information can be crucial for understanding the underlying cause of a person’s symptoms and guiding appropriate medical management and genetic counseling.

Ordering Genetic Testing

NGS testing for MRD9 is typically ordered by a healthcare professional who specializes in genetics. They will consider an individual’s clinical symptoms, family history, and other relevant factors before recommending genetic testing. Genetic counseling is often recommended before and after testing to ensure a thorough understanding of the implications and limitations of the results.

Test Name KIF1A Gene Mental retardation autosomal dominant type 9 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card o
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Neurological Disorders
Doctor Neurologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for KIF1A Gene Mental retardation, autosomal dominant type 9 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with KIF1A Gene Mental retardation, autosomal dominant type 9
Test Details

The KIF1A gene is associated with a condition called mental retardation, autosomal dominant type 9 (MRD9). This genetic test, known as Next-Generation Sequencing (NGS), is used to analyze the DNA sequence of the KIF1A gene to identify any mutations or variations that may be causing MRD9.

MRD9 is a rare genetic disorder characterized by intellectual disability, developmental delays, and other neurological symptoms. Individuals with MRD9 may also experience problems with movement, speech, and coordination. The severity of symptoms can vary widely among affected individuals.

NGS is a powerful genetic testing technique that allows for the rapid and comprehensive analysis of a person’s DNA. It can detect a wide range of genetic mutations and variations, including small changes in the DNA sequence that may be responsible for causing MRD9.

By identifying specific mutations in the KIF1A gene, NGS testing can provide a definitive diagnosis of MRD9. This information can be crucial for understanding the underlying cause of a person’s symptoms and guiding appropriate medical management and genetic counseling.

It is important to note that NGS testing for MRD9 is typically ordered by a healthcare professional who specializes in genetics. They will consider an individual’s clinical symptoms, family history, and other relevant factors before recommending genetic testing. Genetic counseling is often recommended before and after testing to ensure a thorough understanding of the implications and limitations of the results.